Wei Zhao

Wei Zhao is a Postdoctoral Researcher at the University of California, Irvine (UCI), affiliated with Rowland Hall. His work focuses on bioengineering innovations in medical diagnostics, stem cell therapies, and cancer research. Zhao specializes in developing advanced technologies for protein detection, spatial transcriptomics, and exosome-based therapies. His research integrates microfluidics, nanotechnology, and immunology to address challenges in precision medicine and infectious disease surveillance.

Key areas of investigation include:

• Designing low-cost, high-throughput diagnostic systems for clinical applications
• Engineering stem cells for targeted delivery of therapeutic molecules
• Developing multiplex fluorescence imaging techniques for spatial biological profiling
• Exploring exosome-mediated immunomodulation in diabetes and autoimmunity

Zhao's recent work highlights contributions to SARS-CoV-2 seroprevalence studies in healthcare workers, novel bispecific antibody pipelines, and combinatorial labeling strategies for spatial transcriptomics. His technologies aim to bridge the gap between laboratory research and clinical diagnostics.